CLinical Prediction Rule Score in Veterans
| Status: | Withdrawn |
|---|---|
| Conditions: | Gout |
| Therapuetic Areas: | Rheumatology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 4/21/2016 |
| Start Date: | January 2008 |
| End Date: | March 2010 |
Development of CLinical Prediction Rule Score in Veterans: A Study of Impact of Gout on Health Care Utilization and Costs
We will study whether the health care costs and health utilities differ in patients with
gout and those without gout and whether they differ between those with more severe versus
less severe gout
gout and those without gout and whether they differ between those with more severe versus
less severe gout
The purpose of this project is to study the out-patient and inpatient utilization and costs
associated with tophaceous gout (a classic form of treatment-failure gout), compare these
costs to patients with non-tophaceous gout and evaluate health utilities associated with
these gout states. The analyses will be conducted in a manner to support a burden of illness
type of presentation / manuscript.
Study Questions
1. What are the VA health care costs (inpatient and outpatient) for patients with gout
compared to those without gout?
2. Does health utility, as calculated by SF-6D, differ in patients with gout compared to
patients without gout and between tophaceous and non-tophaceous gout?
3. What are the relationships between costs and health utility?
4. How does the burden of illness differ by subgroups of gout patients (costs and
utilities)?
5. What are the VA health care costs for patients with tophaceous gout and are they higher
than patients with non-tophaceous gout?
Inclusion criteria Patients with and without gout from the Veterans database described above
will be included in the analyses for Study aims 1 and 5. This is approximately 3000 gout
patients and 67,000 non-gout patients
Patients with SF-36 data from the above cohort will be included in the analyses for Study
aims 2-4. This is approximately 1500 gout patients and 38,000 non-gout patients
associated with tophaceous gout (a classic form of treatment-failure gout), compare these
costs to patients with non-tophaceous gout and evaluate health utilities associated with
these gout states. The analyses will be conducted in a manner to support a burden of illness
type of presentation / manuscript.
Study Questions
1. What are the VA health care costs (inpatient and outpatient) for patients with gout
compared to those without gout?
2. Does health utility, as calculated by SF-6D, differ in patients with gout compared to
patients without gout and between tophaceous and non-tophaceous gout?
3. What are the relationships between costs and health utility?
4. How does the burden of illness differ by subgroups of gout patients (costs and
utilities)?
5. What are the VA health care costs for patients with tophaceous gout and are they higher
than patients with non-tophaceous gout?
Inclusion criteria Patients with and without gout from the Veterans database described above
will be included in the analyses for Study aims 1 and 5. This is approximately 3000 gout
patients and 67,000 non-gout patients
Patients with SF-36 data from the above cohort will be included in the analyses for Study
aims 2-4. This is approximately 1500 gout patients and 38,000 non-gout patients
Inclusion Criteria:
- participated in the survey
- Have SF-36 adn utilization data
Exclusion Criteria:
- Absence of utilization and/or cost data
We found this trial at
1
site
Click here to add this to my saved trials
